There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. After-hours trades for MaxCyte Inc (MXCT) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.06, or 1.75%, to $3.49. The MaxCyte Inc has recorded 12,468 volume in the after hours trading session. Recently, Yahoo Finance discussed the stock, revealing that MaxCyte Announces Preliminary Third Quarter 2023 Revenue and Updates Full Year 2023 Revenue Guidance.
As a NASDAQ listed company, MXCT falls under the Healthcare sector while operating within the Medical Devices industry segment. At the end of the last regular session, the stock closed at $3.43 and fluctuated between $3.4900 as its day high and $3.2350 as its day low. The current market capitalization of MaxCyte Inc is $355.18M. A total of 1.36 million shares were traded on the day, compared to an average of 731.06K shares.
Aside from predicting where a stock will go, investors also consider insider trades as an indicator of the stock’s future direction. During the recent three months, MXCT has seen 6 BUY and 6 SELL insider trades, representing the acquisition of 10,000 and the disposition of 10,000 shares. Over the last 12 months, there were 48 BUYs and 44 SELLs from insiders. Insiders purchased 621,471 shares during that period but sold 461,471.
In the most recent transaction, Johnston John Joseph sold 2,841 shares of MXCT for 3.70 per share on Aug 30. After the transaction, the Director now owns 120,583 company shares. In a previous transaction on Aug 29, Johnston John Joseph sold 2,059 shares at 3.70 per share. MXCT shares that Director owns now total 120,583.
Among the insiders who sold shares, Johnston John Joseph disposed of 100 shares on Aug 28 at a per-share price of $3.70. This resulted in the Director holding 120,583 shares of MXCT after the transaction. In another insider transaction, Johnston John Joseph sold 5,000 shares at $4.75 per share on Jul 26. Company shares held by the Director now total 120,583.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. According to analysts who have offered 12-month price targets for MXCT in the last 3 months, the mean price target is $9.36 with high estimates of $12.00 and low estimates of $6.00. In terms of 52-week highs and lows, MXCT has a high of $7.41 and a low of $2.45.
As of this writing, MXCT has an earnings estimate of -$0.1 per share for the current quarter. EPS was calculated based on a consensus of 5 estimates, with a high estimate of -$0.08 per share and a lower estimate of -$0.11.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. MXCT’s latest balance sheet shows that the firm has $255.04M in Cash & Short Term Investments as of fiscal 2021. There were $5.68M in debt and $15.62M in liabilities at the time. Its Book Value Per Share was $2.34, while its Total Shareholder’s Equity was $262.90M.
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for MXCT is Buy with a score of 5.00.